On primary outcomes that include brain acetoacetate/glucose metabolism using PET, AD biomarkers, level of serum ketones, safety and feasibility as well as secondary outcomes that include cognition, function and examining key treatment response variables such as APOE genotype, amyloid positivity and metabolic status that could inform precision medicine approaches to dietary prescription. Here, APOE is linked to Alzheimer disease.